NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Revenue

NATCO Pharma had revenue of 4.75B INR in the quarter ending December 31, 2024, a decrease of -37.41%. This brings the company's revenue in the last twelve months to 42.80B, up 11.76% year-over-year. In the fiscal year ending March 31, 2024, NATCO Pharma had annual revenue of 40.02B with 47.76% growth.

• Revenue (ttm): 42.80B
• Revenue Growth: +11.76%
• P/S Ratio: 3.34
• Revenue / Employee: 10.66M
• Employees: 4,016
• Market Cap: 142.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	40.02B	12.94B	47.76%
Mar 31, 2023	27.09B	7.62B	39.17%
Mar 31, 2022	19.46B	-1.10B	-5.35%
Mar 31, 2021	20.56B	1.41B	7.37%
Mar 31, 2020	19.15B	-1.80B	-8.57%